Biblio

Export 335 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
Journal Article
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
Y. E. Cruz-Rivera, Perez-Morales, J., Santiago, Y. M., Gonzalez, V. M., Morales, L., Cabrera-Rios, M., and Isaza, C. E., “A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 193-205, 2018.
B. C. M. Stephan, Birdi, R., Tang, E. Yee Hing, Cosco, T. D., Donini, L. M., Licher, S., M Ikram, A., Siervo, M., and Robinson, L., “Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.
M. Fujishima, Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., and Matsuda, H., “Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 56, no. 1, pp. 75-88, 2017.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
X. - Y. He, Isaacs, C., and Yang, S. - Y., “Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 665-673, 2018.
N. Iwahara, Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., Suzuki, S., and Shimohama, S., “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
C. Cerami, Dodich, A., Greco, L., Iannaccone, S., Magnani, G., Marcone, A., Pelagallo, E., Santangelo, R., Cappa, S. F., and Perani, D., “The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
Y. Hasegawa, Toyama, K., Uekawa, K., Ichijo, H., and Kim-Mitsuyama, S., “Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 259-263, 2018.
S. Abrevaya, Sedeño, L., Fitipaldi, S., Pineda, D., Lopera, F., Buritica, O., Villegas, A., Bustamante, C., Gomez, D., Trujillo, N., Pautassi, R., Ibáñez, A., and García, A. M., “The Road Less Traveled: Alternative Pathways for Action-Verb Processing in Parkinson's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1429-1435, 2017.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
E. Niemantsverdriet, Ribbens, A., Bastin, C., Benoit, F., Bergmans, B., Bier, J. - C., Bladt, R., Claes, L., De Deyn, P. Paul, Deryck, O., Hanseeuw, B., Ivanoiu, A., Lemper, J. - C., Mormont, E., Picard, G., Salmon, E., Segers, K., Sieben, A., Smeets, D., Struyfs, H., Thiery, E., Tournoy, J., Triau, E., Vanbinst, A. - M., Versijpt, J., Bjerke, M., and Engelborghs, S., “A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).”, J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.
V. Solfrizzi, Custodero, C., Lozupone, M., Imbimbo, B. P., Valiani, V., Agosti, P., Schilardi, A., D'Introno, A., La Montagna, M., Calvani, M., Guerra, V., Sardone, R., Abbrescia, D. I., Bellomo, A., Greco, A., Daniele, A., Seripa, D., Logroscino, G., Sabbá, C., and Panza, F., “Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 3, pp. 815-849, 2017.
M. E. Fowler, Wright, N. C., Triebel, K., Rocque, G. B., Irvin, R., and Kennedy, R. E., “The Relationship Between Prior Cancer Diagnosis and All-Cause Dementia Progression Among US Adults.”, J Alzheimers Dis, vol. 88, no. 2, pp. 521-535, 2022.
J. Blautzik, Kotz, S., Brendel, M., Sauerbeck, J., Vettermann, F., Winter, Y., Bartenstein, P., Ishii, K., and Rominger, A., “Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 3, pp. 781-791, 2018.
R. Silva Paradela, Ferreira, N. Vidal, Nucci, M. Penteado, Cabella, B., Martino, L. Menoni, Torres, L. Aló, da Costa, D. Irigoyen, Consolim-Colombo, F. Marciano, Suemoto, C. Kimie, and Irigoyen, M. Claudia, “Relation of a Socioeconomic Index with Cognitive Function and Neuroimaging in Hypertensive Individuals.”, J Alzheimers Dis, vol. 82, no. 2, pp. 815-826, 2021.
M. Elahi, Hasan, Z., Motoi, Y., Matsumoto, S. - E., Ishiguro, K., and Hattori, N., “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R., “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
H. Hamasaki, Honda, H., Okamoto, T., Koyama, S., Suzuki, S. O., Ohara, T., Ninomiya, T., Kiyohara, Y., and Iwaki, T., “Recent Increases in Hippocampal Tau Pathology in the Aging Japanese Population: The Hisayama Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 613-624, 2017.
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
J. Gu, Chen, F., Chu, D., Lu, Y., Iqbal, K., Gong, C. - X., and Liu, F., “Rbfox3/NeuN Regulates Alternative Splicing of Tau Exon 10.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1695-1704, 2018.
J. Niu, Iqbal, K., Liu, F., and Hu, W., “Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.”, J Alzheimers Dis, vol. 82, no. 2, pp. 855-869, 2021.

Pages